EFTA01519388
EFTA01519389 DataSet-10
EFTA01519390

EFTA01519389.pdf

DataSet-10 1 page 115 words document
V15 P17
Open PDF directly ↗ View extracted text
👁 1 💬 0
📄 Extracted Text (115 words)
GHISLAINE MAXWELL - OAP 1HD ACCT. For the Period 2/1/14 to 2/28/14 Equity Summary Beginning Ending Change Current Asset Categories Market Value Market Value In Value Allocation EAFE Equity 1,847,938.92 137 528 10 (1,710,410.82) 100% Current Market Value/Cost Penod Value Market Value 137,528.10 Tax Cost 132,686.12 Unrealized Gain/Loss 4,841.98 Estimated Annual Income 5,106.04 Accrued Dividends 12,566.34 Yield 3.71% Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc Pike Quantity Value Original Cost Gain/Loss Accrued Div. Yield EAFE Equity ASTRAZENECA PLC 67.76 0.00 4.13% SPONS ADR 824.15 046353.108 AZN GLAXOSINDIKUNE PLC 55.94 0.00 4 41% SPONS ADR 684.77 37733W-10.5 GSK JP Morgan Page 4 of 15 Confidential Treatment Requested by JPMorgan JPM-SDNY-00046675 Chase CONFIDENTIAL SDNY_GM_00315873 EFTA01519389
ℹ️ Document Details
SHA-256
fbd5a3a340fe58310cecbff383ffe5af5ed1c5c3f42bd3d415af700f7bbab9ec
Bates Number
EFTA01519389
Dataset
DataSet-10
Document Type
document
Pages
1

Comments 0

Loading comments…
Link copied!